Human varicella zoster IGG elisa assay k - vaccines
Ended Purchase Order Awarded
- Contract number
- HT001418P0244
- Awardee
-
Genway Biotech, LLC UEI Q7KGV5SPMHU6
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $10,176
Award facts
- Contract value 100% obligated
- $10,176.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20889, USA
- Legislative mandates
-
- Clinger-Cohen Act FAR part 39
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract HT001418P0244?
HT001418P0244 was awarded to Genway Biotech, LLC by Defense Health Agency (Department of Defense) on May 29, 2018.
How much is contract HT001418P0244 worth?
The government has obligated $10,176 on HT001418P0244.
Was contract HT001418P0244 competed?
The extent of competition for HT001418P0244 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award